Ligand validation:8PXI

MPD: (4S)-2-METHYL-2,4-PENTANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8PXI_MPD_A_401	48%	88%	0.169	0.913	0.3	0.36	-	-	2	0	100%	1
8Q12_MPD_A_405	70%	87%	0.111	0.928	0.29	0.41	-	-	0	0	100%	1
8Q4B_MPD_A_402	56%	91%	0.117	0.887	0.26	0.3	-	-	0	0	100%	0.699
8Q14_MPD_A_402	53%	90%	0.14	0.899	0.25	0.37	-	-	0	0	100%	1
8Q0Y_MPD_A_403	39%	81%	0.17	0.874	0.29	0.53	-	-	0	0	100%	0.857
8Q13_MPD_A_403	36%	92%	0.172	0.865	0.25	0.27	-	-	0	0	100%	1
9D77_MPD_A_505	100%	87%	0.032	0.998	0.16	0.52	-	-	1	0	100%	1
9H8Q_MPD_B_602	100%	82%	0.039	0.988	0.35	0.44	-	-	1	0	100%	1
7Z6B_MPD_B_307	99%	74%	0.057	0.986	0.42	0.59	-	-	0	0	100%	1
7ZOB_MPD_F_202	99%	72%	0.056	0.983	0.44	0.65	-	-	0	0	100%	1
4H15_MPD_B_313	97%	89%	0.061	0.974	0.33	0.31	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.